# Glympse Bio funding: rounds and investors

> Glympse Bio has raised $40M across 2 rounds since 2018. Investors include Alumni Ventures, Temasek Holdings and ARCH Venture Partners.

Source: https://millionrounds.com/company/glympse-bio (Millionrounds; every figure on the page links to its filing or article)

United States · [Venture startup](https://millionrounds.com/companies)

# Who invested in *Glympse Bio*

2 rounds we have observed, with the 12 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech Healthcare

Funding summary Updated 26 Oct 2026

**$40M** raised across 2 rounds since 2018, from 2 sources

**$22M** Series A **$18M** Venture

- **Latest round:** Venture, $18M Dec 2021
- **Biggest round:** $22M Series A · Oct 2018
- **Investors:** 12

See who backed them

## The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2019 2020 2021

**$22M** Series A

**$18M** Venture

- **First round:** Series A, $22M
- **Biggest round:** $22M
- **Between rounds:** 3.2 years

## The rounds

- **Dec 2021** Venture **$18M** *4 new* [Alumni Ventures](https://millionrounds.com/fund/us-strategic-tech-fund-an-alumni-ventures-fund) [Temasek Holdings](https://millionrounds.com/fund/temasek) [ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) [Catalio Capital Management](https://millionrounds.com/fund/catalio-capital-management) Source recorded SEC filing: $18M sold, first sale Dec 2021
- **Oct 2018** Series A **$22M** *8 new* [GreatPoint Ventures](https://millionrounds.com/fund/greatpoint-ventures) [Yonghua](https://millionrounds.com/fund/yonghua) [Inevitable Ventures](https://millionrounds.com/fund/inevitable-ventures) [Gilead Sciences](https://millionrounds.com/fund/gilead-sciences) [Heritage Provider](https://millionrounds.com/fund/heritage-provider) ARCH Ventures/ Charles River LS Polaris Innovation Fund Rivas Reported by FinSMEs SEC filing: $26M sold, first sale Jul 2018

## Founders and team

From the SEC filings it signed: 6 on the team.

- **Caroline Loew** Executive Officer, Director i
- **Dhaval Winckler Gosalia** Executive Officer i
- **Jessica Winckler Atkinson** Executive Officer i
- **Matthew Winckler Navarro** Executive Officer i
- **Tram Winckler Tran** Executive Officer i
- **Wendy Winckler Adamovich** Executive Officer i

On the board, as filed i *Amy Schulman* *Francis Cuss* *George Zachary* *Robert Langer* *Stanley Lapidus* *Steve Kafka* *Theresia Gouw*

## Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

**Series A** 2018 **Venture** 2021 [Alumni Ventures](https://millionrounds.com/fund/us-strategic-tech-fund-an-alumni-ventures-fund) [Temasek Holdings](https://millionrounds.com/fund/temasek) [ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) [Catalio Capital Management](https://millionrounds.com/fund/catalio-capital-management) [GreatPoint Ventures](https://millionrounds.com/fund/greatpoint-ventures) [Yonghua](https://millionrounds.com/fund/yonghua) [Inevitable Ventures](https://millionrounds.com/fund/inevitable-ventures) [Gilead Sciences](https://millionrounds.com/fund/gilead-sciences) [Heritage Provider](https://millionrounds.com/fund/heritage-provider) ARCH Ventures/ Charles River

## Everyone who backed them

[Alumni Ventures](https://millionrounds.com/fund/us-strategic-tech-fund-an-alumni-ventures-fund) VC firm **1** round

[Temasek Holdings](https://millionrounds.com/fund/temasek) VC firm **1** round

[ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) VC firm **1** round

[Catalio Capital Management](https://millionrounds.com/fund/catalio-capital-management) VC firm **1** round

[GreatPoint Ventures](https://millionrounds.com/fund/greatpoint-ventures) VC firm **1** round

[Yonghua](https://millionrounds.com/fund/yonghua) VC firm **1** round

[Inevitable Ventures](https://millionrounds.com/fund/inevitable-ventures) VC firm **1** round

[Gilead Sciences](https://millionrounds.com/fund/gilead-sciences) Company **1** round

[Heritage Provider](https://millionrounds.com/fund/heritage-provider) VC firm **1** round

ARCH Ventures/ Charles River no record of our own yet **1** round

LS Polaris Innovation Fund no record of our own yet **1** round

Rivas no record of our own yet **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=glympse-bio).

## Quick answers about Glympse Bio

### Who invested in Glympse Bio?

Glympse Bio's investors include Alumni Ventures, Temasek Holdings, ARCH Venture Partners, Catalio Capital Management and GreatPoint Ventures, and 7 more on record.

### How much has Glympse Bio raised?

Glympse Bio has raised $40M across 2 rounds since 2018.

### When did Glympse Bio last raise?

Glympse Bio's most recent round was a Venture of $18M in Dec 2021.

### What was Glympse Bio's biggest round?

Glympse Bio's largest round on record is $22M (Series A), in Oct 2018.

### Who backed Glympse Bio first?

Glympse Bio's first round on record, in Oct 2018, was backed by GreatPoint Ventures, Yonghua and Inevitable Ventures and 5 others.

### What stage is Glympse Bio at?

Glympse Bio's latest named round is a Venture, in Dec 2021.

### Where is Glympse Bio based?

Glympse Bio is based in the United States.

## Companies like Glympse Bio

In the same sector, and raised in the last eighteen months.

[**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**AI** $18M · Oct 2026](https://millionrounds.com/company/ai)[**Baba** $40M · Oct 2026](https://millionrounds.com/company/baba)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app
